Oklahoma Medical Marijuana Businesses Must Secure Federal DEA Registration After DOJ Rescheduling

On April 28 2026, the U.S. Department of Justice reclassified certain marijuana products from Schedule I to Schedule III under the Controlled Substances Act, prompting new federal oversight for entities handling the rescheduled substances.

KXII News12

The Drug Enforcement Administration (DEA) issues federal registrations. The Oklahoma Bureau of Narcotics (OBN) enforces requirement within the state. All Oklahoma medical-marijuana manufacturers and distributors participating in state program must obtain a DEA registration.

KXII News12

The DOJ order was published on April 28 2026, giving businesses a 60-day window from May 1 2026 to June 30 2026 to submit DEA registration applications; the DEA aims to process these within six months. The 60-day filing window starts on April 28 2026, the day of the order’s publication, and runs for 60 days. OBN will begin enforcement on January 1 2027.

KXII News12

Businesses must secure a DEA registration to handle Schedule III marijuana. Applications filed within the 60-day period may operate pending approval. DEA administrator must make “every effort” to complete processing within six months. DEA’s six-month processing target is intended to prevent prolonged operational uncertainty for applicants. Failure to register could trigger revocation of state-issued medical-marijuana license and other penalties.

KXII News12

If a business does not obtain a DEA registration by deadlines, OBN may revoke its state registration, barring it from the medical-marijuana market. Order also references “other penalties,” though details are not provided.

KXII News12

OBN clarified it will not pursue administrative action against non-registered entities until January 1 2027, providing a compliance grace period. Bureau also stressed it cannot dispense legal advice on federal or state law compliance, urging businesses to seek counsel. The bureau’s clarification underscores its role in enforcing state licensing while deferring to federal authority for registration.

KXII News12

• “Department of Justice issued an order on April 28, 2026, rescheduling some marijuana to Schedule III of the Controlled Substances Act.” — U.S. Department of Justice

KXII News12

• “The Oklahoma Bureau of Narcotics says manufacturers and distributors participating in the state’s medical marijuana program are now required to obtain a registration from the Drug Enforcement Administration.” — Oklahoma Bureau of Narcotics

KXII News12

• “Businesses that apply for DEA registration within 60 days of the April 28 publication may continue operating while their application is pending.” — Oklahoma Bureau of Narcotics

KXII News12

• “The bureau added that it cannot provide legal advice concerning compliance with federal law or Oklahoma statutes.” — Oklahoma Bureau of Narcotics

KXII News12

Stakeholders should begin DEA registration process promptly to meet 60-day filing window. Legal counsel will be essential for navigating overlapping federal and state regulations. Timely registration will enable businesses to maintain continuity of patient care under state’s medical program. DEA’s six-month processing goal suggests many businesses could remain operational until the January 2027 enforcement deadline if approval is secured promptly.

KXII News12